Your browser doesn't support javascript.
loading
Regulation of PPARγ2 Stability and Activity by SHP-1.
Kumar, Amit; Laborit Labrada, Beisy; Lavallée-Bourget, Marie-Hélène; Forest, Marie-Pier; Schwab, Michael; Bellmann, Kerstin; Houde, Vanessa; Beauchemin, Nicole; Laplante, Mathieu; Marette, André.
Afiliação
  • Kumar A; Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Faculté de Médecine, Université Laval, Québec, QC, Canada.
  • Laborit Labrada B; Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Faculté de Médecine, Université Laval, Québec, QC, Canada.
  • Lavallée-Bourget MH; Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Faculté de Médecine, Université Laval, Québec, QC, Canada.
  • Forest MP; Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Faculté de Médecine, Université Laval, Québec, QC, Canada.
  • Schwab M; Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Faculté de Médecine, Université Laval, Québec, QC, Canada.
  • Bellmann K; Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Faculté de Médecine, Université Laval, Québec, QC, Canada.
  • Houde V; Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Faculté de Médecine, Université Laval, Québec, QC, Canada.
  • Beauchemin N; Rosalind and Morris Goodman Cancer Research Centre, Departments of Oncology, Medicine and Biochemistry, McGill University, Montreal, QC, Canada.
  • Laplante M; Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Faculté de Médecine, Université Laval, Québec, QC, Canada.
  • Marette A; Centre de Recherche sur le Cancer, l'Université Laval, Québec, QC, Canada.
Mol Cell Biol ; 44(7): 261-272, 2024.
Article em En | MEDLINE | ID: mdl-38828991
ABSTRACT
The protein tyrosine phosphatase Src homology region 2 domain-containing phosphatase-1 (SHP-1) plays an important role in modulating glucose and lipid homeostasis. We previously suggested a potential role of SHP-1 in the regulation of peroxisome proliferator-activated receptor γ2 (PPARγ2) expression and activity but the mechanisms were unexplored. PPARγ2 is the master regulator of adipogenesis, but how its activity is regulated by tyrosine phosphorylation is largely unknown. Here, we found that SHP-1 binds to PPARγ2 primarily via its N-terminal SH2-domain. We confirmed the phosphorylation of PPARγ2 on tyrosine-residue 78 (Y78), which was reduced by SHP-1 in vitro resulting in decreased PPARγ2 stability. Loss of SHP-1 led to elevated, agonist-induced expression of the classical PPARγ2 targets FABP4 and CD36, concomitant with increased lipid content in cells expressing PPARγ2, an effect blunted by abrogation of PPARγ2 phosphorylation. Collectively, we discovered that SHP-1 affects the stability of PPARγ2 through dephosphorylation thereby influencing adipogenesis.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: PPAR gama / Adipogenia / Proteína Tirosina Fosfatase não Receptora Tipo 6 Limite: Animals / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: PPAR gama / Adipogenia / Proteína Tirosina Fosfatase não Receptora Tipo 6 Limite: Animals / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article